Free Publication in 2019
Osamu Yokosuka is an Emeritus Professor of Chiba University, Japan. He graduated from Chiba University School of Medicine in 1975 then worked as a trainee under Professor K. Okuda in Chiba University Hospital till 1978. Dr. Yokosuka was a research fellow worked under Professor S. Scherlock and Professor B. H. Billing in Royal Free Hospital, London, UK from 1978 to 1980; under Professor M. Omata in Chiba University from 1980 to 1985; and under Dr. J Summers in Fox Chase Cancer Center, PA, USA in 1984. In 1985, he received a Degree of Doctor of Medical Science, and served as an Assistant Professor in Chiba University till 1994, then as Lecturer in Medicine till 2006 when he was appointed as Director and Professor of Medicine. From 2013 to 2015, he served as the Dean of Chiba University School of Medicine.
Dr. Yokosuka was the Secretary General of APASL (2008-2014). In 2016, he was elected as the President of APASL Tokyo, the President of 52nd Annual Meeting of Japan Society of Hepatology, and the President of Funabashi Central Hospital. Dr. Yokosuka’s research mainly focuses on Hepatitis and Hepatocellular Carcinoma. So far, he has published more than 700 original papers.
Tatsuo Kanda received a medical degree in 1991 at Niigata University School of Medicine, Japan, and his PhD in 1999 at Chiba University Graduate School of Medicine, Japan. He had post-doctor training for 3 years under Prof. Ratna Ray and Prof. Ranjit Ray at Saint Louis University, St. Louis, MO, USA. In Dec. 2008, Tatsuo Kanda became a Tenure-track Associate Professor at Department of Medicine and Clinical Oncology, Chiba University, Graduate School of Medicine, Japan. In Feb. 2013, Tatsuo Kanda was nominated a permanent Associate Professor at Department of Gastroenterology and Nephrology, Chiba University, Graduate School of Medicine, Japan. In 2017, Tatsuo Kanda became an Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nihon University School of Medicine. For ~25 years, he has focused his scientific interests on the topics related to liver diseases including acute liver failure, viral hepatitis and autoimmune liver diseases, and worked with Prof. Osamu Yokosuka. Tatsuo Kanda is also an expert for hepatitis A virus (HAV), HBV and HCV, and translation and replication of these viruses, and hepatocarcinogenesis. With his expertise in antiviral therapies and hepatitis virus research, Tatsuo Kanda also sees a lot of patients in clinical daily practice. Tatsuo Kanda has published more than 200 articles in peer-reviewed Journal.
Zhao Yang Dong (M’99–SM’06-F'17) obtained Ph.D. degree from the University of Sydney, Australia in 1999. He is currently the SHARP professor and Director of the University of New South Wales Digital Grid Futures Institute, The University of New South Wales, Australia. He is also Director for ARC Research Hub for Integrated Energy Storage Solutions. He was previously Professor and Head of School of Electrical and Information Engineering, University of Sydney, and Ausgrid Chair and Director of the Ausgrid Centre for Intelligent Electricity Networks, the University of Newcastle, Australia. He also held industrial positions with Transend Networks (now TAS Networks), Australia. His research interests include smart grid, power system planning, power system security, renewable energy systems, electricity market, load modelling, and computational intelligence and its application in power engineering. He is serving/served as an editor of IEEE Transactions on Smart Grid, IEEE Power Engineering Letters, and IET Renewable Power Generation.HE is Fellow of IEEE.
Information for register: in order to submit a manuscript, corresponding author(s) and co-authors all need to register in our editorial system first.
Materials to be submitted: A cover letter, the manuscript, supplementary/supporting materials (figure, datasheet, video, etc, are all acceptable) if any, will be asked to submit.
To expedite the review process, please format the manuscript in the following way:
Please download the template for your manuscript preparation.
Type of the article should be determined when preparing the manuscript, and should be indicated at the beginning of the manuscript submission.
LIDSEN journals mainly welcome articles in the following types:
It reports the results of original research, assesses its contribution to the knowledge of a given research area. We consider all submissions as original research manuscripts provided it reports scientific experiments and provides a substantial amount of novel information. A research article usually contains at least: Introduction, Materials and Methods, Results, Discussion, Conclusions and References. Authors should indicate in the manuscript how this study contributes to the current literature.
It summarizes the current state of understanding in a given research area by citing relevant recent studies. It analyzes or discusses the researches that previously published, rather than reporting new experimental results.
It is a concise article focusing on a high-quality, hypothesis-driven, self-contained piece of original research and/or the proposal of a new theory or concept on the basis of current research. It is not intended to publish preliminary results, but should be of significance and broad interest to the scholars in the given research field. A short communication usually contains no more than 3000 words with a few tables and/or figures, and references. Authors should indicate in the manuscript how this hypothesis or proposal contributes to the current literature.
A case report describes the symptoms, signs, diagnosis, treatment, and follow-up of medical cases. It usually refers to an un-reported, unexpected, unusual occurrence. It is usually short and focused with a limited number of tables and/or figures, and references. Authors should indicate in the manuscript how this case report contributes to the current literature.
It describes the process, progress, state or results of a technical or scientific research. It might also include conclusions and recommendations of the research.
It expresses the authors' view about a particular issue. This may be an issue of science policy or urging a particular research agenda, or even taking a side in a particular scientific dispute.
The title of a manuscript should be a concise, specific and informative noun phrase. Abbreviations or formulae should be avoided where possible.
Authors’ full first and last names must be provided. The initials of any middle names are optional. At least one author should be designated as corresponding author. The email addresses of all authors should be provided in the manuscript.
Each author must be affiliated to at least one institute. If author’s affiliation has changed after the study was finished and before the paper was accepted, current affiliation should be indicated as well. The affiliation should be organized in the style: Department, University/Organizational affiliation, City, State/Province (if applicable), Country.
The abstract should be as brief as no more than 300 words and must be structured into separate sections: Background: indicates the purpose of the study; Methods: describes briefly the main methods or experiments applied; Results: summarizes the main findings; Conclusions: indicates the main conclusions or potential implications drawn from the study.
Please minimize the use of abbreviations, and avoid citations in the abstract (any reference to other works should be described in the Abstract and cited in the main text).
Abstract in review articles can be a brief single paragraph different from the above structure.
Each manuscript must contain 3 to 10 keywords that be pertinent to the subject.
A Copyright Agreement must be confirmed by author(s) before manuscript is sent to peer-review. A Copyright Statement will be automatically inserted at the first page of the published paper as following:
©2019 by the authors. This is an open access article distributed under the conditions of the Creative Commons by Attribution License , which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is correctly cited.
It describes the relevant research background, the aims and purposes of the research and its relation with other studies in the field. The working hypothesis should also be clearly stated.
The research should comply with the Research Ethics Guidelines. An individual section Ethics Statement should be provided in the manuscript showing that the research was approved by an appropriate ethics committee or an equivalent institution and conducted ethically.
At least the project identification code, date of approval and name of the ethics committee or institutional review board should be provided in this section.
This section describes the research methodology in sufficient detail that others could reasonably be expected to be able to repeat the work. New methods should be described in detail while well-established methods can be briefly described or appropriately cited. The resources of all materials, data, and protocols involved with the publication should be explained clearly, especially for the materials or information with restricted accesses.
The sequences of oligonucleotides, if not previously published, should be provided.
Novel DNA or protein sequences should be deposited in an appropriate database (e.g., GenBank, EMBL, SWISS-PROT), with the accession numbers included in the manuscript.
Suppliers' names for all antibodies used in the study should be provided.
Methods of statistical analysis should be identified and the statistical software programs used in the study should be cited.
It presents the experimental findings. Tables and figures may be included in this section.
The findings and their implications should be discussed and/or compared with those of other studies. Future research directions may also be recommended in this section.
This is an optional section, which can be included if the discussion is very long or complicated.
In addition to the main authors, those who provided help during the research (e.g., language check, writing assistance, etc.) should be thanked in this section.
For research papers with several authors, a section of Author Contributions, specifying each author’s contribution, should be provided. If it is a review paper or a research paper with single author, this section is not required.
Authors must be those who did substantial contributions to the research. Those who conceived and designed the experiments, acquired and analyzed data, drafted and revised manuscript are considered as authors. We recommend authors to confirm the authorship consulting What Constitutes Authorship? COPE Discussion Document.
Funding resources and grant information should be clarified in this section.
All potential conflicts of interest must be declared in detail. If any patents, patent applications, or products in development or for market were involved, the related information, including patent numbers and titles, should be disclosed. If there is no conflict of interest, please state "The authors have declared that no competing interests exist." in this section.
References, throughout the text, including tables and legends, should be numbered in numerical order. Citation numbers should be included in square brackets ([ ], like , [2,3], [4-8]).
Reference manager, like EndNote, is recommended if a manuscript, especially review article, contains a large number of references. An Vancouver style EndNote template can be downloaded here.
LIDSEN journals follow Vancouver citation style. Frequently used reference types are listed below. For more detailed instructions and examples, please visit: International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals: Sample References and Citing Medicine, 2nd edition.
1. Journal Article:
Author 1 AB, Author 2 CD. (up to 6 authors before using “et al.”) Article title. Abbreviated Journal Name. Year; Volume: pages. (When page is not available, a DOI or other identifier should be provided).
2. Book and Book Chapter:
Author 1 AB, Author 2 CD. Book title. 2nd ed. City of the Publisher: Name of the Publisher; Year of the publication. (page p. or p. page range if any).
Author 1 AB; Author 2 CD. Chapter title. In: Editor 1 AB, Editor 2 CD, editors. Book title. City of the Publisher: Name of the Publisher; Year of the publication. (page p. or p. page range if any).
3. Conference Proceeding:
Author 1 AB, Author 2 CD. Title of the presentation. Proceedings of the Name of the Conference; Full Date of Conference (Year Month Day); Location of Conference (City, State if US, Country). Location of the Publisher (City): Name of the Publisher.
4. Technical Report:
Author 1 AB, Author 2 CD. Report title. Final report. City of the report agency (state abbreviation if US): Name of the agency; year of the report; report number.
Author AB. Title of thesis. City of the University: Name of the university; year of completion.
Author 1 AB, Author 2 CD. Article title [Internet]. City of the press: name of the press; year of update [cited date (year month day)]. Available from: URL.
7. Unpublished Work:
Author 1 AB, Author 2 CD. Title of unpublished work. Abbreviated Journal. Forthcoming year.
To support or supplement the study, additional materials, e.g., text documents, data tables and spreadsheets, static and GIF images, videos, etc., can be published along with the paper. A list of the materials should be provided in the paper, like:
The following additional materials are uploaded at the page of this paper:
Manuscripts submitted to OBM Integrative and Complementary Medicine must be prepared in English. An English translation should be provided if a cited reference was published in another language while the original language should be indicated at the end of the reference.
OBM Integrative and Complementary Medicine has no restrictions on the length of manuscripts, provided that the text is concise and comprehensive.
Calibri, 16 pt for article title, 12 pt for the rest.
Abbreviations should be spelt out when they were firstly referred to.
Units used in the manuscripts submitted to OBM Integrative and Complementary Medicine should be International System of Units (SI). Other units should be converted to SI units. An exception is accepted for blood pressure values (mm Hg should be used).
Figures in EPS, JPG, PNG, PDF, TIFF formats, minimum 1000 pixels or 300 dpi are acceptable. Color figures are preferred while not charged.
All figures should contain a short noun title and a brief explanatory caption. Footnotes should be clearly and correctly marked and explained.
Figures should be ordered in numerical order throughout the paper and inserted in the text close to where they are first cited.
Tables should be prepared in editable Word format, instead of inserted pictures or pieced text.
All tables should contain a brief noun title while all columns should be given an explanatory heading. Footnotes should be clearly and correctly marked and explained.
Tables should be ordered in numerical order throughout the paper and inserted in the text close to where they are first cited.
Equations contained in the manuscript should be prepared by equation editors, e.g., Microsoft Equation Editor built in Word, instead of inserted pictures or pieced text.
After a paper is accepted, authors are encouraged to provide a figure or photo, as Graphic Abstract, to be published on the website along with the paper. The picture should be able to demonstrate all or any of the research theme, subjects, design, conclusion, highlight of its findings.
Static and GIF images are both acceptable. Pictures less than 600 pixels are preferred.